Veeva Systems (VEEV) PT Lowered to $262 at Truist Securities

Truist Securities analyst Jailendra Singh lowered the price target on Veeva Systems (NYSE: VEEV) to $262.00 (from $275.00) while maintaining a Buy rating.

The analyst comments "Veeva delivered a solid FY4Q26, including billings, and issued FY27 guidance that was ahead of consensus across the board. Given cautious peer readthroughs, investors were expecting an in-line quarter and steady outlook. While macro visibility has improved in some areas, guidance assumes no major macro shifts and instead reflects customer planning cycles. Management reaffirmed a ~70% win rate within top-20 pharma, with decisions wrapping up this year. Reiterate Buy; adjust PT to $262 from $27."

You May Also Be Interested In

• Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
• UBS Reiterates Buy Rating on Quanta Services (PWR) Following Meet With Management
• William Blair Downgrades Enovix Corporation (ENVX) to Market Perform